Annovis Bio Secures U.S. Patent for Neuroprotective Drug Buntanetap
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has been granted a U.S. patent for the use of its leading compound, buntanetap, in the treatment and prevention of acute brain and …
Annovis Bio Secures U.S. Patent for Neuroprotective Drug Buntanetap Read More